BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21703991)

  • 1. Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43.
    Chekhonin VP; Baklaushev VP; Yusubalieva GM; Belorusova AE; Gulyaev MV; Tsitrin EB; Grinenko NF; Gurina OI; Pirogov YA
    Nanomedicine; 2012 Jan; 8(1):63-70. PubMed ID: 21703991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of Connexin 43-positive cells of glioma and the periglioma zone by means of intravenously injected monoclonal antibodies.
    Baklaushev VP; Yusubalieva GM; Tsitrin EB; Gurina OI; Grinenko NP; Victorov IV; Chekhonin VP
    Drug Deliv; 2011 Jul; 18(5):331-7. PubMed ID: 21309693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connexin 43-targeted T1 contrast agent for MRI diagnosis of glioma.
    Abakumova T; Abakumov M; Shein S; Chelushkin P; Bychkov D; Mukhin V; Yusubalieva G; Grinenko N; Kabanov A; Nukolova N; Chekhonin V
    Contrast Media Mol Imaging; 2016; 11(1):15-23. PubMed ID: 26265140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylated immunoliposomes directed against brain astrocytes.
    Chekhonin VP; Zhirkov YA; Gurina OI; Ryabukhin IA; Lebedev SV; Kashparov IA; Dmitriyeva TB
    Drug Deliv; 2005; 12(1):1-6. PubMed ID: 15801714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of poorly differentiated glioma using a combination of monoclonal antibodies to extracellular connexin-43 fragment, temozolomide, and radiotherapy.
    Yusubalieva GM; Baklaushev VP; Gurina OI; Zorkina YA; Gubskii IL; Kobyakov GL; Golanov AV; Goryainov SA; Gorlachev GE; Konovalov AN; Potapov AA; Chekhonin VP
    Bull Exp Biol Med; 2014 Aug; 157(4):510-5. PubMed ID: 25110095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of monoclonal antibodies to connexin 43 extracellular fragment in induced low-differentiated glioma.
    Yusubalieva GM; Baklaushev VP; Gurina OI; Gulyaev MV; Pirogov YA; Chekhonin VP
    Bull Exp Biol Med; 2012 May; 153(1):163-9. PubMed ID: 22808518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted transport of 125I-labeled antibody to GFAP and AMVB1 in an experimental rat model of C6 glioma.
    Chekhonin VP; Baklaushev VP; Yusubalieva GM; Gurina OI
    J Neuroimmune Pharmacol; 2009 Mar; 4(1):28-34. PubMed ID: 18770045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of cisplatin by сonnexin 43 vector nanogels to the focus of experimental glioma C6.
    Nukolova NV; Baklaushev VP; Abakumova TO; Mel'nikov PA; Abakumov MA; Yusubalieva GM; Bychkov DA; Kabanov AV; Chekhonin VP
    Bull Exp Biol Med; 2014 Aug; 157(4):524-9. PubMed ID: 25110098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Production and characteristics of PEGylated immunoliposome transport vectors specific for neural tissue astrocytes].
    Chekhonin VP; Zhirkov IuA; Gurina OI; Lebedev SV; Dmitrieva TB; Semenova AV; Iaglova TV; Riabinina AE
    Biomed Khim; 2005; 51(3):276-86. PubMed ID: 16104390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI contrast enhancement by Gd-DTPA-monoclonal antibody in 9L glioma rats.
    Matsumura A; Shibata Y; Nakagawa K; Nose T
    Acta Neurochir Suppl (Wien); 1994; 60():356-8. PubMed ID: 7976589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular imaging of angiogenesis to delineate the tumor margins in glioma rat model with endoglin-targeted paramagnetic liposomes using 3T MRI.
    Qiu LH; Zhang JW; Li SP; Xie C; Yao ZW; Feng XY
    J Magn Reson Imaging; 2015 Apr; 41(4):1056-64. PubMed ID: 24677456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1.
    Baklaushev VP; Nukolova NN; Khalansky AS; Gurina OI; Yusubalieva GM; Grinenko NP; Gubskiy IL; Melnikov PA; Kardashova KSh; Kabanov AV; Chekhonin VP
    Drug Deliv; 2015 May; 22(3):276-85. PubMed ID: 24437962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunofluorescent analysis of connexin-43 using monoclonal antibodies to its extracellular domain.
    Baklaushev VP; Gurina OI; Yusubalieva GM; Grinenko NF; Cytrin EB; Victorov IV; Chekhonin VP
    Bull Exp Biol Med; 2009 Oct; 148(4):725-30. PubMed ID: 20396778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed delivery of VEGF-targeted liposomes into intracranial C6 glioma.
    Shein SA; Nukolova NV; Korchagina AA; Abakumova TO; Kiuznetsov II; Abakumov MA; Baklaushev VP; Gurina OI; Chekhonin VP
    Bull Exp Biol Med; 2015 Jan; 158(3):371-6. PubMed ID: 25573371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro study of novel gadolinium-loaded liposomes guided by GBI-10 aptamer for promising tumor targeting and tumor diagnosis by magnetic resonance imaging.
    Gu MJ; Li KF; Zhang LX; Wang H; Liu LS; Zheng ZZ; Han NY; Yang ZJ; Fan TY
    Int J Nanomedicine; 2015; 10():5187-204. PubMed ID: 26316749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connexin-43 antibodies in intraoperative diagnosis of experimental poorly differentiated gliomas.
    Iusubalieva GM; Zorkina IaA; Baklaushev VP; Gurina OI; Goriaĭnov SA; Aleksandrova EV; Zhukov VIu; Savel'eva TA; Potapov AA; Chekhonin VP
    Zh Vopr Neirokhir Im N N Burdenko; 2014; 78(3):3-13. PubMed ID: 25146651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human interferon beta gene transfer upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells.
    Mizuno M; Yoshida J
    Cancer Immunol Immunother; 1998 Dec; 47(4):227-32. PubMed ID: 9875676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells.
    Lin JH; Takano T; Cotrina ML; Arcuino G; Kang J; Liu S; Gao Q; Jiang L; Li F; Lichtenberg-Frate H; Haubrich S; Willecke K; Goldman SA; Nedergaard M
    J Neurosci; 2002 Jun; 22(11):4302-11. PubMed ID: 12040035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biodegradation of 125I-labeled monoclonal antibodies after introvenous administration to rats with experimental C6 glioma].
    Chekhonina VP; Bulanov KA; Iusubalieva GM; Tsibul'kina EA; Gurina OI; Skoblov IuA; Shvets VI; Zhirkv IuA; Baklaushev VP
    Biomed Khim; 2007; 53(5):532-40. PubMed ID: 18078067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.